Clinical validation of artificial intelligence (AI) is still a long way off, admits Dr. Hugh Harvey, who moderated the Artificial Intelligence Exhibition (AIX) at ECR 2019 with Dr. Wim Van Hecke, CEO of icometrix in Leuven, Belgium. In this interview, Harvey, clinical director at Kheiron Medical, reflects on the future development of AI and the unresolved issues that need to be addressed.
Clinical validation of artificial intelligence (AI) is still a long way off, admits Dr. Hugh Harvey, who comoderated the Artificial Intelligence Exhibition (AIX) with Dr. Wim Van Hecke. He reflects on the future development of AI and the unresolved issues that need to be addressed.Video from ECR 2019: Hugh Harvey on validation of AI
Mar 2, 2019
Latest in Home
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)
